UNSPSC 51144112: Chlorphentermine

This classification denotes a cns stimulant with the molecular formula C10H14ClN, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) NHW07912O7, chemically known as 4-chloro-.alpha.,.alpha.-dimethylphenethylamine hydrochloride but more generally known as chlorphentermine, which bears US NIH Compound Identifier 10007. European Medicines Agency schedules Chlorphentermine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06205MIG.

UNSPSC 51144112 Chlorphentermine is a Commodity code that in practice covers pharmaceutical products and controlled-substance management supplies procured by state and local health agencies. The recent solicitation record shows that governments are acquiring naloxone (an opioid-reversal medication) and drug deactivation systems — products aligned with community health and public-safety initiatives rather than the specific pharmaceutical compound the code nominally names. State and local procurement under this code spans county health departments and community health programs seeking to stock emergency pharmaceuticals and related equipment through competitive bidding.

Seminole County, Florida, posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. The county required electronic bid submission through its e-Procurement Portal, compliance with E-Verify and drug-free workplace certification, and inclusion of all shipping and delivery costs in pricing. The contract offered a two-year initial term with a one-year renewal option and potential FEMA funding, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act.